Factor VIII coagulant activity >5%
1 drugsPredictive biomarker for patient selection in 5 indications
1
Approved Drugs
5
Indications
1
Companies
Factor VIII coagulant activity >5% is a precision-medicine biomarker linked to 1 FDA-approved targeted drug from 1 company, spanning 5 indications including Central Diabetes Insipidus, Polyuria, Polydipsia. Explore the targeted therapies, indications, testing methods, and companies developing Factor VIII coagulant activity >5% drugs below.
Search Factor VIII coagulant activity >5% Clinical Trials
Search recruiting trials on ClinicalTrials.gov
Drugs Targeting Factor VIII coagulant activity >5%
| Drug | Company | Therapeutic Area |
|---|---|---|
| DDAVP | FERRING PHARMS INC | Rare Disease |
Factor VIII coagulant activity >5% Indications
Central Diabetes Insipidus Polyuria Polydipsia Hemophilia A von Willebrand's Disease